CN109452521A - 一种降尿酸肽固体饮料、制备方法及用途 - Google Patents
一种降尿酸肽固体饮料、制备方法及用途 Download PDFInfo
- Publication number
- CN109452521A CN109452521A CN201811599533.0A CN201811599533A CN109452521A CN 109452521 A CN109452521 A CN 109452521A CN 201811599533 A CN201811599533 A CN 201811599533A CN 109452521 A CN109452521 A CN 109452521A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- solid beverage
- trioxypurine
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007787 solid Substances 0.000 title claims abstract description 71
- 235000013361 beverage Nutrition 0.000 title claims abstract description 69
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 45
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 34
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 32
- 229940088594 vitamin Drugs 0.000 claims abstract description 28
- 229930003231 vitamin Natural products 0.000 claims abstract description 28
- 235000013343 vitamin Nutrition 0.000 claims abstract description 28
- 239000011782 vitamin Substances 0.000 claims abstract description 28
- 229920001202 Inulin Polymers 0.000 claims abstract description 22
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 22
- 229940029339 inulin Drugs 0.000 claims abstract description 22
- 241000251468 Actinopterygii Species 0.000 claims abstract description 21
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 19
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 18
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 18
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 18
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 18
- 239000001556 apium graveolens l. seed extract Substances 0.000 claims abstract description 18
- 229940116732 celery seed extract Drugs 0.000 claims abstract description 18
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 18
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229960000304 folic acid Drugs 0.000 claims abstract description 17
- 235000019152 folic acid Nutrition 0.000 claims abstract description 17
- 239000011724 folic acid Substances 0.000 claims abstract description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 16
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 16
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims abstract description 16
- 239000001095 magnesium carbonate Substances 0.000 claims abstract description 16
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims abstract description 16
- 235000014380 magnesium carbonate Nutrition 0.000 claims abstract description 16
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 16
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 16
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 16
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 16
- 239000011718 vitamin C Substances 0.000 claims abstract description 16
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims abstract description 15
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 15
- 239000004225 ferrous lactate Substances 0.000 claims abstract description 15
- 235000013925 ferrous lactate Nutrition 0.000 claims abstract description 15
- 229940037907 ferrous lactate Drugs 0.000 claims abstract description 15
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 15
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 15
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 15
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 12
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 11
- 229960003495 thiamine Drugs 0.000 claims abstract description 11
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 11
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 10
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 10
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 10
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 10
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960002477 riboflavin Drugs 0.000 claims abstract description 9
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 8
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 8
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 27
- 235000010469 Glycine max Nutrition 0.000 claims description 21
- 244000197580 Poria cocos Species 0.000 claims description 18
- 235000013305 food Nutrition 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 claims 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims 1
- 241000209140 Triticum Species 0.000 claims 1
- 235000009754 Vitis X bourquina Nutrition 0.000 claims 1
- 235000012333 Vitis X labruscana Nutrition 0.000 claims 1
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 235000014787 Vitis vinifera Nutrition 0.000 claims 1
- 235000019504 cigarettes Nutrition 0.000 claims 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract description 44
- 230000000694 effects Effects 0.000 abstract description 36
- 201000005569 Gout Diseases 0.000 abstract description 18
- 230000036039 immunity Effects 0.000 abstract description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 8
- 235000010755 mineral Nutrition 0.000 abstract description 8
- 239000011707 mineral Substances 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 7
- 210000000056 organ Anatomy 0.000 abstract description 7
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 6
- 230000008439 repair process Effects 0.000 abstract description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 5
- 208000026435 phlegm Diseases 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 210000002700 urine Anatomy 0.000 abstract description 5
- 230000001771 impaired effect Effects 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 206010037660 Pyrexia Diseases 0.000 abstract description 3
- 206010025482 malaise Diseases 0.000 abstract description 3
- 238000001179 sorption measurement Methods 0.000 abstract description 3
- 241001619444 Wolfiporia cocos Species 0.000 abstract 1
- 229960001708 magnesium carbonate Drugs 0.000 abstract 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 19
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 19
- 229940116269 uric acid Drugs 0.000 description 19
- 239000000047 product Substances 0.000 description 17
- 235000019688 fish Nutrition 0.000 description 16
- 230000006870 function Effects 0.000 description 16
- 239000003814 drug Substances 0.000 description 14
- 230000004060 metabolic process Effects 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 230000029142 excretion Effects 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 230000009102 absorption Effects 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 8
- 230000004144 purine metabolism Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 108010085443 Anserine Proteins 0.000 description 7
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 7
- 241000210053 Potentilla elegans Species 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 5
- 108010087806 Carnosine Proteins 0.000 description 5
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 229940044199 carnosine Drugs 0.000 description 5
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 240000007087 Apium graveolens Species 0.000 description 3
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 3
- 235000010591 Appio Nutrition 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 240000008892 Helianthus tuberosus Species 0.000 description 3
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 201000001431 Hyperuricemia Diseases 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000001387 apium graveolens Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 235000001055 magnesium Nutrition 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000036559 skin health Effects 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- NTDLXWMIWOECHG-UHFFFAOYSA-N 7-labden-3beta,15-diol Natural products O1CC(O)(CO)C(O)C1OC1C(O)C(O)C(CO)OC1OC(C=1)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 NTDLXWMIWOECHG-UHFFFAOYSA-N 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 241001415328 Alopochen aegyptiaca Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- SLRNWACWRVGMKD-QMMMGPOBSA-N Balenine Chemical compound CN1C=NC(C[C@H](N=C(O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-QMMMGPOBSA-N 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 241000269819 Katsuwonus pelamis Species 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 240000003915 Lophatherum gracile Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 206010035039 Piloerection Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- IAPCTXZQXAVYNG-UHFFFAOYSA-M Potassium 2,6-dihydroxytriazinecarboxylate Chemical compound [K+].[O-]C(=O)C1=NC(=O)NC(=O)N1 IAPCTXZQXAVYNG-UHFFFAOYSA-M 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010046337 Urate nephropathy Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- NTDLXWMIWOECHG-YRCFQSNFSA-N apiin Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O[C@H]1[C@@H]([C@@](O)(CO)CO1)O)O)CO)C(C=1)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 NTDLXWMIWOECHG-YRCFQSNFSA-N 0.000 description 1
- NTDLXWMIWOECHG-WJAPLXOZSA-N apiin Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C=C(c3ccc(O)cc3)Oc2c1)[C@H]1[C@@H](O)[C@@](O)(CO)CO1 NTDLXWMIWOECHG-WJAPLXOZSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 201000006334 interstitial nephritis Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000005067 joint tissue Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- -1 meanwhile Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical class [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229950000193 oteracil Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000010382 simiaowan Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 229940091251 zinc supplement Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种降尿酸肽固体饮料、制备方法及用途，涉及固体饮料技术领域，该固体饮料的组份为：麦芽糊精，大豆肽粉，芹菜籽提取物，茯苓粉，海洋鱼低聚肽，低聚异麦芽糖，菊粉，维生素C，碳酸镁，烟酸，乳酸亚铁，葡萄糖酸锌，维生素B1，维生素B2，维生素B6，叶酸。应用主料和辅料，主要以小分子肽、矿物质、微量元素、维生素等相互配合调节人体各系统功能，使五脏六腑功能正常，修复受损的细胞，提高免疫力，增强清热祛湿的功效，化痰清热，利湿软坚，清热通络、平衡阴阳，改善身体排泄功能，并抑制嘌呤在身体的吸收转化，促进嘌呤随尿液排出机体外部，对降尿酸和预防痛风有明显的作用，同时利于消除其他不适症状。
Description
技术领域：
本发明涉及固体饮料技术领域，具体涉及一种降尿酸肽固体饮料、制备方法及用途。
背景技术：
随着人们生活水平的提高、生活节奏和生活方式的改变，日常膳食不可避免的趋向高盐、高糖，高脂，高蛋白，由盐、鱼、肉、海鲜、饮酒、少运动而带来的现代文明病富贵病“四高”症高血压、高血糖、高血脂、高尿酸(HUA)日趋严重，其中尿酸值升高的人群越来越年轻化。痛风常伴腹型肥胖、高脂血症、高血压、2型糖尿病及心血管病等表现。
痛风(gout)是由单钠尿酸盐(MSU)沉积所致的晶体相关性关节病，与嘌呤代谢紊乱和(或)尿酸排泄减少所致的高尿酸血症直接相关，当高尿酸血症持续存在时，会以单尿酸结晶沉积在关节或软组织上，促发急性关节的疼痛，一般表现为单关节不对称性的急性红、肿、热、痛，时候也会有自然的缓解，持续的高尿酸血症还可能会形成痛风石，另外还有可能影响到内脏，引起痛风性肾病、冠心病、高血糖、高血脂、脂肪肝等，高尿酸引起的痛风性急性关节炎反复发作、痛风石沉积痛风石性慢性关节炎和关节畸形，常累及肾脏引起慢性间质性肾炎和尿酸肾结石形成。目前，中西医均有许多药物和方法对治疗高尿酸有一定的效果，但也有不足之处，具体如下：西医治疗的方法通常是服用西药，有些是抗炎、止痛类药、有些药物或通过抑制黄嘌呤酶、或通过抑制尿酸在肾小管的重吸收，它们对身体副作用很大，特别是对肾的副作用很大，且治表不治根，无法根治，产生胃肠道刺激(恶心、呕吐)、消化性溃疡或穿孔等副作用。中医采用中药治疗高尿酸或痛风，采用清热利湿为主，结合个体发病特点，或佐以健脾益气，或佐以化痰活血，使痰湿热瘀之内生浊邪得化，气血通调，而病症痊愈，或杜绝其发作。故其治疗的原理更类似于西医改善嘌呤代谢的方法，并可同样改善脂肪代谢、糖代谢和能量代谢，在应用中有一定的功效，但由于痛风治疗的长期性，上班族的患者更愿意选择具有上述治疗作用的中成药，如痛风定胶囊和四妙丸，需中长期使用，不能作为单纯的止痛药或降尿酸药时用时停，在急性痛风发作期仍需配合消炎止痛类西药同时运用，有对身体副作用很大的缺点。
发明内容：
本发明的目的是为了克服上述现有技术存在的不足之处，而提供一种降尿酸肽固体饮料。本发明的另一个目的是提供一种降尿酸肽固体饮料的制备方法及其用途。
本发明采用的技术方案为：一种降尿酸肽固体饮料，所述的固体饮料的组份为：麦芽糊精，大豆肽粉，芹菜籽提取物，茯苓粉，海洋鱼低聚肽，低聚异麦芽糖，菊粉，维生素C，碳酸镁，烟酸，乳酸亚铁，葡萄糖酸锌，维生素B1，维生素B2，维生素B6，叶酸。
优选的，所述的固体饮料的组份为：麦芽糊精20-25份，大豆肽粉20-25份，芹菜籽提取物5-8份，茯苓粉5-8份，海洋鱼低聚肽5-8份，低聚异麦芽糖5-8份，菊粉5-8份，维生素C0.0006-0.225份，碳酸镁0.0006-0.225份，烟酸0.0006-0.225份，乳酸亚铁0.0006-0.225份，葡萄糖酸锌0.0006-0.225份，维生素B1 0.0006-0.225份，维生素B2 0.0006-0.225份，维生素B6 0.0006-0.225份，叶酸0.0006-0.225份。
优选的，所述的固体饮料的组份为：麦芽糊精22-25份，大豆肽粉23-25份，芹菜籽提取物5-6份，茯苓粉5-6份，海洋鱼低聚肽7-8份，低聚异麦芽糖7-8份，菊粉7-8份，维生素C0.001-0.12份，碳酸镁0.001-0.12份，烟酸0.001-0.12份，乳酸亚铁0.001-0.12份，葡萄糖酸锌0.001-0.12份，维生素B1 0.001-0.12份，维生素B2 0.001-0.12份，维生素B6 0.001-0.12份，叶酸0.001-0.12份。
优选的，所述的固体饮料的组份为：麦芽糊精25份，大豆肽粉25份，芹菜籽提取物5份，茯苓粉5份，海洋鱼低聚肽8份，低聚异麦芽糖8份，菊粉8份，维生素C 0.001份，碳酸镁0.001份，烟酸0.001份，乳酸亚铁0.001份，葡萄糖酸锌0.001份，维生素B1 0.001份，维生素B2 0.001份，维生素B6 0.001份，叶酸0.001份。
本发明的另一个发明目的所采用的技术方案为：一种降尿酸肽固体饮料的制备方法，该方法包括以下步骤：
步骤一：按照固体饮料各组份的含量进行称重，称重后将所有组份均加入搅拌罐中搅拌10-30min，搅拌速度10-35rpm/s；
步骤二：干燥杀菌后使产品成型，将成型后的产品分装成小包装。
上述中的降尿酸肽固体饮料在制备降尿酸的食品或保健品中的用途。
麦芽糊精的甜度低，易消化，低热，含有大量的多糖类，极易被人体吸收，提供机体新陈代谢的能量，在本发明中麦芽糊精除了易吸收及低热外，还起到加速并促进该固体饮料中的其他成分溶解在热水中，提高固体饮料的冲调性，同时，麦芽糊精能促进机体对营养物质吸收和加速废料物质的代谢。
大豆肽粉是以大豆粕或大豆蛋白等为主要原料，用酶解或微生物发酵法生产，其是由2-6个氨基酸组成的混合肽。大豆肽粉中含有人体所必需的9种氨基酸，9种氨基酸参与机体内多种活用酶的合成，促进该固体饮料中的多种活性物质及营养物质的吸收利用，而且对活性物质和营养物质的吸收不受身体状况差异的影响。大豆肽粉在本发明中的作用机理是：大豆肽粉含有多种生物活性肽，易被人体消化吸收，同时通过蛋白质的改性作用消除了身体对营养物质的抑制因子，促进营养物质的消化吸收和利用，此外，在本发明中，大豆肽粉能通过刺激甲状腺素分泌，促使胆汁酸化，使胆固醇排出体外而达到降低胆固醇的作用，通过抑制嘌呤的合成与加速嘌呤排泄而实现降低尿酸的作用，同时，还能抑制血管紧张素转换酶的活性，防止血管末梢收缩并能引起皮下脂肪的减少，抑制自由基的过氧化作用，加速受损细胞修复，保持机体活力，减少色素沉着的发生，增强机体免疫力，维护正常细胞代谢，延缓细胞衰老，实现抗氧化、降血压、降低胆固醇、降血脂、降血糖、抗疲劳、增强免疫和激素调节、抗菌、抗病毒、预防肥胖等作用。
芹菜籽提取物(固体)是以伞形花科草本植物芹菜籽为原料，萃取芹菜籽油，喷雾干燥制取芹菜籽油微胶囊产品，芹菜是日常食用的蔬菜。芹菜籽提取物含有多种药理活性成分,黄酮类芹菜甙、芹菜素、多酚类、挥发油、佛手柑内酯、生物碱、有机酸等物质。本发明中的芹菜籽提取物与大豆肽粉相互配合，实现抑制体内自由基氧化作用，清除自由基，实现增强体质并预防衰老，预防肿瘤，降低肿瘤发病率，具有散气、消肿、利尿、抗肿瘤、抗衰老等功效。同时芹菜籽提取物与该固体饮料中的其他成分相互配合，实现增强体质，修复受损内脏，降四高等功效。
菊粉是以菊苣或菊芋(别名洋姜、鬼子姜)等为原料，经粉碎、提取等而成，菊粉是植物中储备性多糖。作用机理：菊粉有膳食纤维的功效，不能被消化系统吸收，其热量低、水溶性、促进肠道收缩并能增强肠道双歧杆菌增殖，菊粉到达肠道后首先被双歧杆菌利用生成醋酸盐和乳酸盐，降低大肠的PH值，从而抑制了病原菌的生长并促进益生菌的增殖，益生菌增殖后能够促进该固体饮料中的营养物质、有益物质以及食物中的营养物质和矿物质的消化吸收。菊粉与其他成分协同作用可以起到促进肠道消化吸收营养物质并抑制嘌呤的合成因子，加速嘌呤代谢，从而起到降尿酸、恢复肠胃功能、对防治大肠癌有特效、增强矿物质钙质吸收等功能。
茯苓性味甘、淡、平，归心、肺、脾、肾经，载于《神农本草经》，列为上品。其具有利水渗湿、健脾宁心的功效，常用于治疗水肿尿少、痰饮眩悸、脾虚食少、便溏泄泻、心神不安、惊悸失眠等。现代药理学研究表明，茯苓具有调节免疫功能、抗肿瘤、抗炎、抗衰老等多方面药理作用。本产品中添加茯苓主要依于其利尿的功效，茯苓与该固体饮料中的其他成分相配合利湿软坚、降低对嘌呤的吸收和合成，并通过利尿而加速嘌呤的排泄，降低身体内嘌呤的含量，对于痛风之红肿胀痛及痛风结节坚硬不化均有较好疗效。
海洋鱼低聚肽(鲣鱼肉提取物(含鹅肌肽))从海洋鱼类主要是西太平洋洄游鱼类金枪鱼科鲣(jiān)鱼中提取分离的蛋白质低聚肽，主要是高度稳定的水溶性二肽，即鹅肌肽(β-丙氨酰-1-甲基L-组氨酸，Anserine)与肌肽。以鹅肌肽为主、肌肽为辅的低分子量提取物，纯净无污染。鹅肌肽及肌肽能够促进嘌呤代谢，起到抗疲劳效果。功效成份：鹅肌肽又名安肌肽，安肌肽的pK值为7.1。作用机理：鹅肌肽能够调剂机体PH值、维持肌肉内部的酸碱平衡，螯合金属离子、清除自由基、抗氧化、抗衰老、抗疲劳、调整荷尔蒙代谢、神经调节等，同时改善嘌呤代谢通路中各种蛋白酶酶活，改善嘌呤代谢紊乱，降低尿酸生成和累积量，促进尿酸排泄，保护肾脏。鹅肌肽的含量范围为10-30％。
低聚异麦芽糖属于非消化低聚糖类，具有水溶性膳食纤维的功能，其甜度、热量低，基本不增加血糖血脂。此外，它能够促进肠道内双歧杆菌等有益菌的增殖，抑制有害菌的生长，提高肠道内维生素的合成以及矿物质的吸收，增强人体免疫功能。低聚异麦芽糖、菊粉以及海洋鱼低聚肽相互配合，改变肠道PH值，提高酶活性，改善肠道内菌株环境，促进有益菌生长并抑制有害菌的繁殖，有益菌株的生长繁殖可以促进营养物质的吸收利用，同时抑制有害物质例如嘌呤的吸收、合成与转换，并加速有害物质的排泄，改善体内的微环境，提高身体免疫力，从根源上降低尿酸含量。
维生素C在本发明中可以对抗游离基、有助于防癌，降低胆固醇，加强身体免疫力，防止坏血病。维生素C与芹菜籽提取物、大豆肽粉相互作用相互促进，实现消除自由基，避免自由基氧化，提高嘌呤代谢中的多种酶的活性，增强身体内脏的代谢能力，改善体质，增强抵抗力并促进嘌呤代谢排出机体。
碳酸镁是一款镁补充剂。碳酸镁可以为机体合成活性酶提供镁元素并提高机体酶激活剂的合成与含量，酶激活剂与酶结合促进酶活性的提高，使嘌呤的代谢增强，促进骨的形成，维持神经和肌肉兴奋性，心血管保护因子，利尿导泄，使嘌呤代谢废物排出体内，而实现降低尿酸。
烟酸在本发明中起到保持皮肤健康及促进血液循环，有助神经系统正常工作、增强身体抵抗力，修复受损细胞，提高酶活性等功效，强健消化系统，有助于皮肤的保健及美容，改善偏头痛、高血压、腹泻、加速血液循环，治疗口疮，消除口臭，减少胆固醇。
乳酸亚铁是一种铁补充剂。为身体代谢提供充足的铁元素，并参与体内氧的运送和组织呼吸过程，血红蛋白和肌红蛋白的成分，与红细胞形成和成熟有关，催化β-胡萝卜素转化维生素A，胶原合成，增强免疫力和肝脏解毒力，进一步促进嘌呤的代谢和排泄。
葡萄糖酸锌是一种锌补充剂，葡萄糖酸锌为身体提供充足的锌含量，促进机体内合成多种活性酶，促进血糖、血脂、胆固醇及尿酸等的代谢，根治身体内部代谢紊乱、排泄紊乱等问题，促进生长发育、性器官和性功能正常发育、食欲、维生素A代谢，参与免疫功能的创建和增强，保护皮肤健康，改善亚健康状态，使身体保持活力。
维生素B1(盐酸硫胺)可以强化神经系统，保证心脏正常活动，促进碳水化合物之新陈代谢，能维护神经系统健康，稳定食欲，刺激生长以及保持良好的肌肉状况。
维生素B2(核黄素)维持眼睛视力，防止白内瘴，维持口腔及消化道粘膜的健康。促进碳水化合物、脂肪与蛋白质之新陈代谢，并有助于形成抗体及红血球，维持细胞呼吸。
维生素B6(盐酸吡哆醇)保持身体及精神系统正常工作，维持体内钠，钾成份平衡，制造红血球。调节体液，增进神经和骨骼肌肉系统正常功能，是天然的利尿剂。
叶酸制造红血球及白血球,增强免疫能力。叶酸、维生素B2、烟酸等成分相互配合作用促进机体内免疫抗体的合成，增强身体的抗病力与免疫力，同时修复身体受伤的细胞并调节身体内部嘌呤、血糖等的代谢紊乱及排泄紊乱等问题，从根源上改善身体质量，促进身体五脏六腑的对营养物质的吸收并加速有害物质的排泄作用，营造一个稳定协和的身体内环境，通过身体自身的抵抗力与身体自身的代谢来实现降尿酸的功能，避免中西药对身体的毒害作用。
同时维生素B6、维生素B2、维生素B1等成分相互配合，协调身体内部的排泄功能，改善肠道环境，促进嘌呤等对身体有害物质的排泄，并促进微量元素的吸收利用，改善机体内环境，避免脂肪、嘌呤等在身体内集聚。
本发明的有益效果为：本发明应用主料和辅料，主要以小分子肽、矿物质、微量元素、维生素等相互配合调节人体各系统功能，使五脏六腑功能正常，修复受损的细胞，提高免疫力，增强清热祛湿的功效，化痰清热，利湿软坚，清热通络、平衡阴阳，改善身体排泄功能，并抑制嘌呤在身体的吸收转化，促进嘌呤随尿液排出机体外部，对降尿酸和预防痛风有明显的作用，同时利于消除其他不适症状。该固体饮料来源于多种植物提取精华，其组份均为药食同源的食品，提高效果，对身体无毒副作用，长期服用可以调理身体，增强身体体质，改善身体内环境及肠道代谢能力，最终实现增强体质，预防多种急性及慢性疾病的发生。该固体饮料为机体提供具有生物活性的小分子肽、矿物质、微量元素、维生素等营养素，满足身体合成多种活性酶、抗体等物质的需要，同时这些营养物质在人体内相互补充、协同、增效、取长补短，满足人体需要的同时改善人体内环境。通过提高营养素生物价，提高食物的吸收利用率，不然营养素就象木桶的短板，营养素再多也只能浪费掉，同时也具有提高免疫力、调节五脏六腑功能，有降高尿酸的功效，避免痛风的发生并治疗痛风。
具体实施方式：
结合具体实施例对本发明进行进一步说明：
实施例一：
一种降尿酸肽固体饮料，所述的固体饮料的组份为：麦芽糊精25份，大豆肽粉25份，芹菜籽提取物5份，茯苓粉5份，海洋鱼低聚肽8份，低聚异麦芽糖8份，菊粉8份，维生素C0.001份，碳酸镁0.001份，烟酸0.001份，乳酸亚铁0.001份，葡萄糖酸锌0.001份，维生素B10.001份，维生素B2 0.001份，维生素B6 0.001份，叶酸0.001份。
实施例二：
一种降尿酸肽固体饮料，所述的固体饮料的组份为：麦芽糊精20份，大豆肽粉20份，芹菜籽提取物8份，茯苓粉8份，海洋鱼低聚肽5份，低聚异麦芽糖5份，菊粉5份，维生素C0.0006份，碳酸镁0.0006份，烟酸0.0006份，乳酸亚铁0.0006份，葡萄糖酸锌0.0006份，维生素B1 0.0006份，维生素B2 0.0006份，维生素B6 0.0006份，叶酸0.0006份。
实施例三：
一种降尿酸肽固体饮料，所述的固体饮料的组份为：麦芽糊精22份，大豆肽粉22份，芹菜籽提取物7份，茯苓粉7份，海洋鱼低聚肽6份，低聚异麦芽糖6份，菊粉7份，维生素C0.225份，碳酸镁0.225份，烟酸0.225份，乳酸亚铁0.225份，葡萄糖酸锌0.225份，维生素B10.225份，维生素B2 0.225份，维生素B6 0.225份，叶酸0.225份。
实施例四：
一种降尿酸肽固体饮料，所述的固体饮料的组份为：麦芽糊精24份，大豆肽粉24份，芹菜籽提取物6份，茯苓粉6份，海洋鱼低聚肽6份，低聚异麦芽糖6份，菊粉7份，维生素0.1份，碳酸镁0.1份，烟酸0.1份，乳酸亚铁0.1份，葡萄糖酸锌0.01份，维生素B1 0.2份，维生素B2 0.1份，维生素B6 0.03份，叶酸0.07份。
实施例一至实施例四中的固体饮料采用以下制备方法制备：该制备方法包括以下步骤：
步骤一：按照固体饮料各组份的含量进行称重，称重后将所有组份均加入搅拌罐中搅拌10-30min，搅拌速度10-35rpm/s；优选的搅拌时间为30min，搅拌速度为25rpm/s；
步骤二：干燥杀菌后使产品成型，将成型后的产品分装成小包装，每袋质量相等，每小包5g。本发明中的产品的成型方法采用常规的成型方法，具体为：该固体饮料可以制成粉末状，干燥杀菌后产品即为粉末状，可以直接将产品分装成小袋包装，每袋1-10g，优选为每袋5g。该固体饮料也可以制成颗粒状，具体为：干燥杀菌后，可以采用干法制粒机进行干压，再将所得条块通过摇摆式颗粒机制成颗粒，再将颗粒状的产品分装成小袋包装。此外，产品制粒过程也可以采用常规的湿法制粒过程。该固体饮料也可以制成冲剂，在干燥杀菌后将粉末状产品溶解在灭菌后的水中制成冲剂，水的用量为10-50ml，制成冲剂后可以采用瓶装、袋装或者常用的冲剂包装材料进行包装。该固体饮料也可以制成片状，在干燥杀菌后通过挤压成片状产品。根据产品销售和使用需要，也可以将本产品制成其他常用的形态。
实施例一至实施例四中的降尿酸肽固体饮料可以用于制备降尿酸的食品或保健品。本配方中的固体饮料采用食物的方式，一天冲饮3包，每包5克，可以为身体提供有效的小分子肽，同时在降尿酸和减轻痛风症状有明显的作用。本发明固体饮料中的麦芽糊精与菊粉可以替换为淡竹叶粉0.1-0.5份，决明子提取物1-2份，柠檬粉3-5份，黄精粉5-10份，玉米须粉5-10份，山楂粉1-2份，玛咖粉15-17份，香蕉粉10-15份，荷叶粉2-4份，紫苏粉7-10份，淮山粉5-7份。替换后的固体饮料的风味更佳、口感更好，且在保持降尿酸的基础上为身体提供更充足的营养，增强体质，修复受损细胞，利尿加速嘌呤的代谢和排泄。
对照例一：
一种降尿酸肽固体饮料，所述的固体饮料的组份为：麦芽糊精25份，大豆肽粉25份，芹菜籽提取物5份，茯苓粉5份，海洋鱼低聚肽8份，低聚异麦芽糖8份，菊粉8份。
对照例二：
一种降尿酸肽固体饮料，所述的固体饮料的组份为：茯苓粉5份，海洋鱼低聚肽8份，低聚异麦芽糖8份，菊粉8份，维生素C 0.001份，碳酸镁0.001份，烟酸0.001份，乳酸亚铁0.001份，葡萄糖酸锌0.001份，维生素B1 0.001份，维生素B2 0.001份，维生素B6 0.001份，叶酸0.001份。
对照例三：
一种降尿酸肽固体饮料，所述的固体饮料的组份为：麦芽糊精25份，大豆肽粉25份，芹菜籽提取物5份，维生素C 0.001份，碳酸镁0.001份，烟酸0.001份，乳酸亚铁0.001份，葡萄糖酸锌0.001份，维生素B1 0.001份，维生素B2 0.001份，维生素B6 0.001份，叶酸0.001份。
使用效果实验：
(1)动物试验：
选取SD大鼠，从大鼠中随机选取10只大鼠作为正常组，剩余的大鼠用来建模，造模组大鼠每天灌胃氧嗪酸钾(2g.kg-1)，正常组大鼠每天灌胃给予等体积的溶媒；连续7天后，注射麻醉，眼眶后静脉取血，离心取上层血清测定尿酸含量，将建模成功的大鼠随机分成模型组、实施例一组、实施例二组、实施例三组、实施例四组、对照1组、对照2组、对照3组。每组有10只大鼠；正常组与模型组均给予等体积的生理盐水，实施例一组使用本发明中实施例一中的用饮用水冲泡的固体饮料；实施例二组使用实施例二中的固体饮料；实施例三组使用实施例三中的固体饮料；实施例四组使用实施例四中的固体饮料；对照1组使用本发明中对照例一中的用饮用水冲泡的固体饮料；对照2组使用对照例二中的固体饮料；对照3组使用对照例三中的固体饮料。
实验组和对照组的给药剂量为1g.kg-1.d-1。每组均喂养三个月，各组动物均于第0周和第12周的周日上午8:00取血，测定血清中尿酸含量。
具体结果见下表：
从上表中，可以看出本发明中的实施例一在降低血尿酸含量方面的效果最佳，本发明中的各个组份不是单一起作用，是通过各个组份之间的相互协同作用，才能在降尿酸方面取得具有显著的作用。本发明中的固体饮料无毒无副作用，由于是食源性，可以长期食用而不会产生耐药性，通过长期使用可以起到降尿酸的作用，并提高身体本身的抵抗力，通过身体本身的抵抗力来调节嘌呤代谢紊乱和嘌呤排泄紊乱等问题，从根本上预防痛风的发生。
(2)临床试验：
案例一：
大连市于先生，不到30岁，服用之前尿酸值560umol/L，服用一个月后，尿酸值降到410，回到正常值，人也感觉比之前有精气神。
案例二：
广州番禺区某小区李老师，男，服用之前尿酸值510umol/L，服用一个月后，尿酸值降到390，回到正常值，人也感觉比之前有精气神。
案例三：
家住佛山在南沙某公司入职的员工钟某，50多岁，男，服用之前尿酸值410umol/L，有痛风症状，服用一个月后，尿酸值降到310，人也感觉比之前有精气神。
综上所述，本发明在降尿酸方面具有显著的成效，服用一个月左右即可使血液中尿酸含量恢复正常，长期服用身体的抵抗力及精气神均得到很大的提高。
本发明的技术方案应用主料和辅料，主要以小分子肽、矿物质、微量元素、维生素等相互配合调节人体各系统功能，使五脏六腑功能正常，修复受损的细胞，提高免疫力，增强清热祛湿的功效，化痰清热，利湿软坚，清热通络、平衡阴阳，改善身体排泄功能，并抑制嘌呤在身体的吸收转化，促进嘌呤随尿液排出机体外部，对降尿酸和预防痛风有明显的作用，同时利于消除其他不适症状。该固体饮料来源于多种植物提取精华，其组份均为药食同源的食品，提高效果，对身体无毒副作用，长期服用可以调理身体，增强身体体质，改善身体内环境及肠道代谢能力，最终实现增强体质，预防多种急性及慢性疾病的发生。该固体饮料为机体提供具有生物活性的小分子肽、矿物质、微量元素、维生素等营养素，满足身体合成多种活性酶、抗体等物质的需要，同时这些营养物质在人体内相互补充、协同、增效、取长补短，满足人体需要的同时改善人体内环境。通过提高营养素生物价，提高食物的吸收利用率，不然营养素就象木桶的短板，营养素再多也只能浪费掉，同时也具有提高免疫力、调节五脏六腑功能，有降高尿酸的功效，避免痛风的发生并治疗痛风。
对于本领域的技术人员来说，可根据以上技术方案以及构思，做出其他各种相应的改变以及变形，而所有的这些改变和变形都应该属于本发明权利要求的保护范围之内。
Claims (6)
1.一种降尿酸肽固体饮料，其特征在于：所述的固体饮料的组份为：麦芽糊精，大豆肽粉，芹菜籽提取物，茯苓粉，海洋鱼低聚肽，低聚异麦芽糖，菊粉，维生素C，碳酸镁，烟酸，乳酸亚铁，葡萄糖酸锌，维生素B1，维生素B2，维生素B6，叶酸。
2.根据权利要求1所述的降尿酸肽固体饮料，其特征在于：所述的固体饮料的组份为：麦芽糊精20-25份，大豆肽粉20-25份，芹菜籽提取物5-8份，茯苓粉5-8份，海洋鱼低聚肽5-8份，低聚异麦芽糖5-8份，菊粉5-8份，维生素C 0.0006-0.225份，碳酸镁0.0006-0.225份，烟酸0.0006-0.225份，乳酸亚铁0.0006-0.225份，葡萄糖酸锌0.0006-0.225份，维生素B10.0006-0.225份，维生素B2 0.0006-0.225份，维生素B6 0.0006-0.225份，叶酸0.0006-0.225份。
3.根据权利要求1所述的降尿酸肽固体饮料，其特征在于：所述的固体饮料的组份为：麦芽糊精22-25份，大豆肽粉23-25份，芹菜籽提取物5-6份，茯苓粉5-6份，海洋鱼低聚肽7-8份，低聚异麦芽糖7-8份，菊粉7-8份，维生素C 0.001-0.12份，碳酸镁0.001-0.12份，烟酸0.001-0.12份，乳酸亚铁0.001-0.12份，葡萄糖酸锌0.001-0.12份，维生素B1 0.001-0.12份，维生素B2 0.001-0.12份，维生素B6 0.001-0.12份，叶酸0.001-0.12份。
4.根据权利要求1所述的降尿酸肽固体饮料，其特征在于：所述的固体饮料的组份为：麦芽糊精25份，大豆肽粉25份，芹菜籽提取物5份，茯苓粉5份，海洋鱼低聚肽8份，低聚异麦芽糖8份，菊粉8份，维生素C 0.001份，碳酸镁0.001份，烟酸0.001份，乳酸亚铁0.001份，葡萄糖酸锌0.001份，维生素B1 0.001份，维生素B2 0.001份，维生素B6 0.001份，叶酸0.001份。
5.一种降尿酸肽固体饮料的制备方法，其特征在于：该方法包括以下步骤：
步骤一：按照固体饮料各组份的含量进行称重，称重后将所有组份均加入搅拌罐中搅拌10-30min，搅拌速度10-35rpm/s；
步骤二：干燥杀菌后使产品成型，将成型后的产品分装成小包装。
6.一种如权利要求1至4中任一项所述的降尿酸肽固体饮料在制备降尿酸的食品或保健品中的用途。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811599533.0A CN109452521B (zh) | 2018-12-26 | 2018-12-26 | 一种辅助降尿酸肽固体饮料、制备方法及用途 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811599533.0A CN109452521B (zh) | 2018-12-26 | 2018-12-26 | 一种辅助降尿酸肽固体饮料、制备方法及用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109452521A true CN109452521A (zh) | 2019-03-12 |
| CN109452521B CN109452521B (zh) | 2022-05-17 |
Family
ID=65615182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811599533.0A Active CN109452521B (zh) | 2018-12-26 | 2018-12-26 | 一种辅助降尿酸肽固体饮料、制备方法及用途 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109452521B (zh) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110101082A (zh) * | 2019-05-15 | 2019-08-09 | 河北华北制药华恒药业有限公司 | 一种具有降尿酸和抗过敏双重功效的功能食品 |
| CN110354140A (zh) * | 2019-07-30 | 2019-10-22 | 任步海 | 预防内酸盐针状沉淀物引发痛风的奥氏晶体和制备方法 |
| CN110583780A (zh) * | 2019-10-14 | 2019-12-20 | 广西景红健康产业有限公司 | 一种可以预防和降低高血压和高尿酸的固体饮料 |
| CN110651862A (zh) * | 2019-11-21 | 2020-01-07 | 李海齐 | 一种能够促进喝茶后降低尿酸的口服固体饮料及其制备方法 |
| CN110731442A (zh) * | 2019-11-28 | 2020-01-31 | 江云 | 一种祛湿消水肿的活性肽固体饮料及其制备方法 |
| CN111000973A (zh) * | 2019-12-22 | 2020-04-14 | 重庆申高生化制药股份有限公司 | 具有改善痛风功效的组合物及其应用 |
| CN111567782A (zh) * | 2020-06-17 | 2020-08-25 | 陆菊华 | 一种能够降血糖的生物味精 |
| CN111671078A (zh) * | 2020-04-17 | 2020-09-18 | 山东哈维药业有限公司 | 含克弗尔发酵乳粉的血管养护组合物及其制备方法 |
| CN111990570A (zh) * | 2020-09-01 | 2020-11-27 | 广东微纳生物科技有限公司 | 一种降尿酸固体饮料及其制备方法以及加工设备 |
| CN112237591A (zh) * | 2019-07-19 | 2021-01-19 | 深圳市长卿医学研究院 | 一种含叶酸的抗痛风组合物 |
| CN115177634A (zh) * | 2022-07-26 | 2022-10-14 | 武汉英纽林生物科技有限公司 | 一种抗痛风组合物及其制备方法与应用 |
| CN115211517A (zh) * | 2022-08-05 | 2022-10-21 | 新乡绿健园药食同源研究院有限公司 | 一种具有降尿酸功效的固体饮料及其制备方法 |
| CN116077580A (zh) * | 2022-09-21 | 2023-05-09 | 彤博士健康产业河北有限公司 | 一种降尿酸组合物及其制备工艺 |
| CN116326708A (zh) * | 2022-06-09 | 2023-06-27 | 宜春四叶草生物科技有限公司 | 补充人体微量元素和能量的块状固体饮料及其制备方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102077933A (zh) * | 2010-09-20 | 2011-06-01 | 王强 | 一种高尿酸患者专用的海洋特膳食品 |
| UA88508U (uk) * | 2013-07-03 | 2014-03-25 | Державна Установа "Національний Інститут Терапії Ім. Л.Т. Малої Намн України" | Спосіб корекції порушень пуринового обміну у хворих на артеріальну гіпертензію з метаболічним синдромом |
| CN105077270A (zh) * | 2015-07-16 | 2015-11-25 | 上海冬泽特医食品有限公司 | 一种营养强化复合粉、其制备方法及用途 |
| CN106616177A (zh) * | 2016-11-28 | 2017-05-10 | 广东中顺华功生物科技有限公司 | 一种具有降尿酸疗效的复合多肽固体饮料及其制备方法 |
| CN106805234A (zh) * | 2016-12-19 | 2017-06-09 | 江苏红瑞制药有限公司 | 一种降尿酸食品组合物 |
| CN108850366A (zh) * | 2018-08-08 | 2018-11-23 | 广州宏韵医药科技股份有限公司 | 一种具有降尿酸作用的代用茶组合物及其制备方法 |
-
2018
- 2018-12-26 CN CN201811599533.0A patent/CN109452521B/zh active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102077933A (zh) * | 2010-09-20 | 2011-06-01 | 王强 | 一种高尿酸患者专用的海洋特膳食品 |
| UA88508U (uk) * | 2013-07-03 | 2014-03-25 | Державна Установа "Національний Інститут Терапії Ім. Л.Т. Малої Намн України" | Спосіб корекції порушень пуринового обміну у хворих на артеріальну гіпертензію з метаболічним синдромом |
| CN105077270A (zh) * | 2015-07-16 | 2015-11-25 | 上海冬泽特医食品有限公司 | 一种营养强化复合粉、其制备方法及用途 |
| CN106616177A (zh) * | 2016-11-28 | 2017-05-10 | 广东中顺华功生物科技有限公司 | 一种具有降尿酸疗效的复合多肽固体饮料及其制备方法 |
| CN106805234A (zh) * | 2016-12-19 | 2017-06-09 | 江苏红瑞制药有限公司 | 一种降尿酸食品组合物 |
| CN108850366A (zh) * | 2018-08-08 | 2018-11-23 | 广州宏韵医药科技股份有限公司 | 一种具有降尿酸作用的代用茶组合物及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 刘永乐: "《稻米及其制品生产技术问答》", 31 August 2010, 科学普及出版社 * |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110101082A (zh) * | 2019-05-15 | 2019-08-09 | 河北华北制药华恒药业有限公司 | 一种具有降尿酸和抗过敏双重功效的功能食品 |
| CN112237591A (zh) * | 2019-07-19 | 2021-01-19 | 深圳市长卿医学研究院 | 一种含叶酸的抗痛风组合物 |
| CN112237591B (zh) * | 2019-07-19 | 2022-05-31 | 深圳奥萨医药有限公司 | 一种含叶酸的抗痛风组合物 |
| CN110354140A (zh) * | 2019-07-30 | 2019-10-22 | 任步海 | 预防内酸盐针状沉淀物引发痛风的奥氏晶体和制备方法 |
| CN110583780A (zh) * | 2019-10-14 | 2019-12-20 | 广西景红健康产业有限公司 | 一种可以预防和降低高血压和高尿酸的固体饮料 |
| CN110651862A (zh) * | 2019-11-21 | 2020-01-07 | 李海齐 | 一种能够促进喝茶后降低尿酸的口服固体饮料及其制备方法 |
| CN110731442A (zh) * | 2019-11-28 | 2020-01-31 | 江云 | 一种祛湿消水肿的活性肽固体饮料及其制备方法 |
| CN111000973A (zh) * | 2019-12-22 | 2020-04-14 | 重庆申高生化制药股份有限公司 | 具有改善痛风功效的组合物及其应用 |
| CN111671078A (zh) * | 2020-04-17 | 2020-09-18 | 山东哈维药业有限公司 | 含克弗尔发酵乳粉的血管养护组合物及其制备方法 |
| CN111567782A (zh) * | 2020-06-17 | 2020-08-25 | 陆菊华 | 一种能够降血糖的生物味精 |
| CN111990570A (zh) * | 2020-09-01 | 2020-11-27 | 广东微纳生物科技有限公司 | 一种降尿酸固体饮料及其制备方法以及加工设备 |
| CN116326708A (zh) * | 2022-06-09 | 2023-06-27 | 宜春四叶草生物科技有限公司 | 补充人体微量元素和能量的块状固体饮料及其制备方法 |
| CN115177634A (zh) * | 2022-07-26 | 2022-10-14 | 武汉英纽林生物科技有限公司 | 一种抗痛风组合物及其制备方法与应用 |
| CN115211517A (zh) * | 2022-08-05 | 2022-10-21 | 新乡绿健园药食同源研究院有限公司 | 一种具有降尿酸功效的固体饮料及其制备方法 |
| CN116077580A (zh) * | 2022-09-21 | 2023-05-09 | 彤博士健康产业河北有限公司 | 一种降尿酸组合物及其制备工艺 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109452521B (zh) | 2022-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109452521A (zh) | 一种降尿酸肽固体饮料、制备方法及用途 | |
| CN101574140B (zh) | 一种具有增强人体免疫功能和抗疲劳作用的饮品组合物 | |
| KR101738912B1 (ko) | 비만억제 및 다이어트 조성물 | |
| CN102077939B (zh) | 一种肥胖人士专用的海洋特膳食品 | |
| CN104856003A (zh) | 糖尿病非全营养配方食品 | |
| CN104855967A (zh) | 肥胖、减脂手术非全营养配方食品 | |
| CN100403932C (zh) | 一种增强记忆力的营养粉 | |
| CN102077934A (zh) | 一种高血压患者专用的海洋特膳食品 | |
| CN104855985A (zh) | 尿酸高非全营养配方食品 | |
| CN102077945A (zh) | 一种人流、产后专用的海洋特膳食品 | |
| CN104855994A (zh) | 肾病非全营养配方食品 | |
| CN102077937A (zh) | 一种中青年女士专用的海洋特膳食品 | |
| CN104855975A (zh) | 肌肉衰减综合征非全营养配方食品 | |
| CN104855997A (zh) | 骨质疏松非全营养配方食品 | |
| CN104856000A (zh) | 失眠非全营养配方食品 | |
| CN104855968A (zh) | 肝癌非全营养配方食品 | |
| CN103977206A (zh) | 改善肠胃消化系统功能的中药制剂及其生产方法 | |
| CN1401758A (zh) | 一种制备食疗保健醋的方法及用该方法生产的食疗保健醋 | |
| CN104855976A (zh) | 降三高壮阳非全营养配方食品 | |
| CN102077943A (zh) | 一种记忆力衰退者专用的海洋特膳食品 | |
| CN104839704A (zh) | 壮阳非全营养配方食品 | |
| CN104839671A (zh) | 壮阳医学配方食品 | |
| CN104489472A (zh) | 一种治疗消化不良、腹泻的食品 | |
| CN109805235B (zh) | 一种辅助降四高的麦香复合多肽固体饮料、制备方法及用途 | |
| CN104855989A (zh) | 脾胃虚寒非全营养配方食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder |
Address after: 701, Building 2, No. 9, Dabu Road, Huadu District, Guangzhou, Guangdong 510000 Patentee after: GUANGDONG YANGMU SPECIAL MEDICAL FOOD CO.,LTD. Address before: 510000 factory building B, No. 68, Xintang team, Xialuo village, Jiangpu street, Conghua District, Guangzhou City, Guangdong Province Patentee before: GUANGDONG YANGMU SPECIAL MEDICAL FOOD CO.,LTD. |
|
| CP02 | Change in the address of a patent holder |